Acino, part of Arcera Recognized Among Ukraine’s Top Employers
Acino, part of Arcera in Ukraine has been named one of the Top 50 best employers in Ukraine and ranked...
News
Ariprazol® Receives Qualification Release in the EU and Launches Sales in Latvia
Acino, part of Arcera, has obtained a qualification release for its prescription antipsychotic medicine Ariprazol® (aripiprazole) in the European Union,...
Acino South Africa certified as Top Employer
Acino South Africa has been certified as a Top Employer by the independent Top Employers Institute for the fifth consecutive...
Arcera Life Sciences releases inaugural Sustainability Report
The 2024 report outlines Arcera’s current ESG initiatives and long-term ambitions, including a firm commitment to achieving full carbon neutrality...
Acino Iraq Recognised as Best Place to Work
We are thrilled to announce that Acino, part of Arcera, has been certified as one of the Best Place to...
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer’s Disease
Seongnam-si, South Korea and Abu Dhabi, UAE – June 10, 2025 – AriBio Co., Ltd. (“AriBio”), a South Korean biopharmaceutical company...
Achieving Level 1 B-BBEE status in South Africa for the sixth year in a row
For the sixth consecutive year, Acino has achieved Level 1 Broad-Based Black Economic Empowerment (B-BBEE) contributor status in South Africa.
Acino Recognized Among Ukraine’s Top 50 Best Employers — Again!
Forbes Ukraine, in collaboration with robota.ua, has once again included Acino in its list of Ukraine's Top 50 Best Employers.
Top Employer 2025: Acino South Africa achieves certification for the fourth consecutive year
We are delighted to announce that Acino South Africa has been recognised as a Top Employer for 2025, marking the...